HuGE Literature Finder
Records
1
-
3
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. EBioMedicine 2020 Nov 62 103103. Dietz Steffen, Christopoulos Petros, Yuan Zhao, Angeles Arlou Kristina, Gu Lisa, Volckmar Anna-Lena, Ogrodnik Simon J, Janke Florian, Fratte Chiara Dalle, Zemojtel Tomasz, Schneider Marc A, Kazdal Daniel, Endris Volker, Meister Michael, Muley Thomas, Cecchin Erika, Reck Martin, Schlesner Matthias, Thomas Michael, Stenzinger Albrecht, Sültmann Holg |
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy. Clinical lung cancer 2015 Dec . Ulivi Paola, Chiadini Elisa, Dazzi Claudio, Dubini Alessandra, Costantini Matteo, Medri Laura, Puccetti Maurizio, Capelli Laura, Calistri Daniele, Verlicchi Alberto, Gamboni Alessandro, Papi Maximilian, Mariotti Marita, De Luigi Nicoletta, Scarpi Emanuela, Bravaccini Sara, Turolla Gian Michele, Amadori Dino, Crinò Lucio, Delmonte Ange |
Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer. Breast cancer research and treatment 2012 Jul 134 (2): 561-7. Grob Tobias J, Heilenkötter Uwe, Geist Stefan, Paluchowski Peter, Wilke Christian, Jaenicke Fritz, Quaas Alexander, Wilczak Waldemar, Choschzick Matthias, Sauter Guido, Lebeau Annet |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: